470
5.
6.
7.
8.
9.
BÖLÜM 15 • ÇOCUK VE ADOLESANLARDA DİABETES MELLİTUS
TM, Haberland H, Raile K, Ellars S, Flanagan SE, Hattersley AT,
Holl RW. Entities and frequency of neonatal diabetes: data from the
diabetes documentation and quality management system (DPV).
Diabetic Medicine 2010;27:709-712.
Stuy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, LipkindGM, Lipton RB, Greeley SAW,
Patch A; Ellard E, Steiner DF, Hattersley AT, Philipson LH, Bell GI.
Insulin gene mutations as a cause of permanent neonatal diabetes.
PNAS 2007;104(38):15040-15044.
Garin I, Edghill EL, Akerman I, Rubio-Cabezas O, Rica I, Locke
JM, Maestro MA, Alshaikh A, Bundak R, Castillo G, Deeb A, Deiss
D, Fernandez JM, Godbole K, Hussain K, O’Connell M, Klupa T,
Kolouskova S, Mohsin F, Perlman K, Sumnik Z, Rial JM, Ugarte E,
Vasanthi T, Neonatal Diabetes International Group, Johnstone K,
Flanagan SE, Rosa Martínez R, Castaño C, Patch AM, FernándezRebollo E, Raile K, Morgan N, Harries LW, Castaño L, Ellard S, Ferrer J, de Nanclares GP, and Hattersley AT. Recessive mutations in
the INS gene result in neonatal diabetes through reduced insulin
biosynthesis. Proc Natl Acad Sci 2010;107(7):3105-3110.
Njolstad PR, Sovik O, Cuesta-Munoz A, et al Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001;
344:1588-92.
Njolstad PR, Sagen JV, Bjorkhaug L, Odili S, Permanent neonatal
diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52:2854-60.
Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P. Familial hyperglycemia due to
mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med. 1993; 328:697-702.
10. Meissner T, Beinbrech B, Mayatepek E. Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat 1999;
13:351-61.
11. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the
human IPF1 gene coding sequence. Nat Genet 1997;15:106-10.
12. Stoffers DA, Ferrer J, Clarke WL, Habener JF (1997) Early-onset
type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet
1997;17:138-9.
13. Rubio-Cabezas O, Minton JAL, Kantor I, Williams D, Ellard S, Hattersley AT. Homozygous mutations in NEUROD1 are responible
for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes 2010;59(9):2326-31.
14. Rubio-Cabezas O, Minton JAL, Caswell R, Shield JP, Deiss D, Sumnik Z, Cayssial A, Herr M, Loew A, Lewis V, Ellard S, Hattersley AT.
Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009;32 (1):
111-116.
15. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare
Dis 2010;5:29-38.
16. Dimitri P, Warner JT, Minton JAL, Patch MA, Ellard S, Hattersley
AT, Barr S, Hawkes D, Wales JK, Gregory JW. Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol 2010;164:1-7.
17. Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec JC, Charon C, Nicolino M, Boileau P, Cavener DR, Bougneres P, Taha D,
Julier C. Mutations in GLIS3 are responsible for a rare syndrome
with neonatal diabetes mellitus and congenital hypothyroidism. Nat
Genet 2006;38:682–7.